Follow WHA71 with the PHM Watch Team

Posted Tue, 2018-05-15 10:52

The provisional agenda (A71/1) is pasted in below (see also the official documents page).  Not all official documents have yet been posted (although the anticipated links have been inserted below). 

An integrated PHM commentary on agenda items for which secretariat documents have been published (as of 14 May) is here (A71/16 Add./1 and A71/27 still missing).  Further comments will be published as the remaining official documents are published.  Feedback to edit[at]phmovement.org will be most welcome. 

See also the WHO Tracker for further links to relevant documents and previous discussions and resolutions.  Explore the Items Search and Resolutions Search functions.  

Plenary

1. Opening of the Health Assembly

1.1 Appointment of the Committee on Credentials

1.2 Election of the President

1.3 Election of the five Vice-Presidents, the Chairmen of the main committees, and establishment of the General Committee

1.4 Adoption of the agenda and allocation of items to the main committees (A71/1)

2. Report of the Executive Board on its 139th and 140th sessions (A71/2)

    • PHM Commentary on EB141 Index
    • PHM Commentary on EB142 Index
    • PHM Commentary on EBSS4 on GPW13

3. Address by  Dr Tedros Adhanom Ghebreyesus, Director-General (A70/3)

4. Invited speakers

5. Admission of new Members and Associate Members [if any]

6. Executive Board: election

7. Awards (A71/INF./1)

8. Reports of the main committees

9. Closure of the Health Assembly

Committee A

10. Opening of the Committee

11. Strategic priority matters

11.1 Draft thirteenth general programme of work, 2019–2023 (A71/4, A71/4 Add.1 and EB142.R2) (PHM)

11.2 Public health preparedness and response (PHM)

  • Report of the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme (A71/5)
  • WHO’s work in health emergencies (A71/6)
  • Implementation of the International Health Regulations (2005) (A71/7, A71/8EB142(1))

11.3 Polio transition and post-certification (A71/9) (PHM)

11.4 Health, environment and climate change (A71/10 and A71/11) (PHM)

11.5 Addressing the global shortage of, and access to, medicines and vaccines (A71/12, EB142(3)) (PHM) ✓

11.6 Global strategy and plan of action on public health, innovation and intellectual property (A71/13, EB142(4)) (PHM) ✓

11.7 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018 (A71/14 and A71/14 Add.1) (PHM)

11.8 Preparation for a high-level meeting of the General Assembly on ending tuberculosis (A71/15, A71/16, A71/16 Add.1 and EB142.R3) (PHM)

12. Other technical matters

12.1 Global snakebite burden (A71/17 and EB142.R4) (PHM) ✓

12.2 Physical activity for health (A71/18 and EB142.R5) (PHM) ✓

12.3 Global Strategy for Women’s, Children’s and Adolescents’ Health (2016–2030): sexual and reproductive health, interpersonal violence, and early childhood development (A71/19) (PHM) ✓

12.4 mHealth (A71/20) (PHM) ✓

12.5 Improving access to assistive technology (A71/21 and EB142.R6) (PHM) ✓

12.6 Maternal, infant and young child nutrition (PHM) ✓

  • Comprehensive implementation plan on maternal, infant and young child nutrition: biennial report (A71/22)
  • Safeguarding against possible conflicts of interest in nutrition programmes (A71/23)

12.7 Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits (A71/24, A71/24 Add.1 and A71/42) (PHM)

12.8 Rheumatic fever and rheumatic heart disease (A71/25 and EB141.R1) (PHM)

12.9 Eradication of poliomyelitis (A71/26 and A71/26 Add.1) (PHM) ✓

COMMITTEE B

13. Opening of the Committee

14. Health conditions in the occupied Palestinian territory, including East Jerusalem, and in the occupied Syrian Golan (A71/27) (PHM)

15. Programme budget and financial matters

15.1 WHO programmatic and financial reports for 2016–2017, including audited financial statements for 2017 (A71/28, A71/29 and A71/INF./2) (PHM)

15.2 Financing of the Programme budget 2018–2019 (A71/30) (PHM)

15.3 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution (A71/31)

15.4 Special arrangements for settlement of arrears [if any]

15.5 Assessment of new Members and Associate Members [if any]

15.6 Amendments to the Financial Regulations and Financial Rules [if any]

16. Audit and oversight matters

16.1 Report of the External Auditor (A71/32) (PHM)

16.2 Report of the Internal Auditor (PHM)

    • Annual report (A71/33)
    • External and internal audit recommendations: progress on implementation (A71/34)

17. Staffing matters

17.1 Human resources: annual report (A71/35) (PHM)

17.2 Report of the International Civil Service Commission (A71/36) 

17.3 Amendments to the Staff Regulations and Staff Rules (A71/37 and EB142.R8 and EB142.R9)

17.4 Appointment of representatives to the WHO Staff Pension Committee (A71/38)

18. Management and legal matters

18.1 Agreements with intergovernmental organizations [if any]

19. Collaboration within the United Nations system and with other intergovernmental organizations

20. Matters for information

20.1 Global vaccine action plan (A71/39) (PHM) ✓

20.2 Real estate: update on the Geneva buildings renovation strategy (A71/40)

20.3 Progress reports (A71/41) (PHM)

Communicable diseases

A. Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, for the period 2016–2021 (WHA69.22 (2016))

B. Eradication of dracunculiasis (WHA64.16 (2011))

C. Elimination of schistosomiasis (WHA65.21 (2012), A68/36(PR2015))

Noncommunicable diseases

D. Public health dimension of the world drug problem (WHA70(18) (2017))

E. Global burden of epilepsy and the need for coordinated action at the country level to address its health, social and public knowledge implications (WHA68.20 (2015))

F. Comprehensive mental health action plan 2013−2020 (WHA66.8 (2013))

G. Comprehensive and coordinated efforts for the management of autism spectrum disorders (WHA67.8 (2014))

Promoting health through the life course

H. Global strategy and action plan on ageing and health 2016–2020: towards a world in which everyone can live a long and healthy life (WHA69.3 (2016))

Health systems

I. Promoting the health of refugees and migrants (WHA70.15 (2017))

J. Strengthening integrated, people-centred health services (WHA69.24 (2016))

K. Promoting innovation and access to quality, safe, efficacious and affordable medicines for children (WHA69.20 (2016))

L. Sustainable health financing structures and universal coverage (WHA64.9 (2011))

M. Availability, safety and quality of blood products (WHA63.12 (2010))

N. Human organ and tissue transplantation (WHA63.22 (2010))

O. WHO strategy on research for health (WHA63.21 (2010))

P. Workers’ health: global plan of action (WHA60.26 (2007))

Health emergencies programme

Q. Smallpox eradication: destruction of variola virus stocks (WHA60.1 (2007))

Corporate services/enabling functions

R. Multilingualism: implementation of action plan (WHA61.12 (2008))